The genes coding for three proteins of the plasma lipid transport system-apolipoproteins Al (APOAI), C3 (APOC3), and A4 (APOA4)-are closely linked and tandemly organized on the long arm of human chromosome 11. In this study the human APOA4 gene has been isolated and characterized. In contrast to APOAl and APOC3 genes, which contain three introns, the APOA4 gene contains only two. An intron interrupting the 5' noncoding region of the APOA1 and APOC3 mRNAs is absent from the corresponding position of the APOA4 mRNA. However, similar to APOAI and APOC3 genes, the introns of the APOA4 gene separate nucleotide sequences coding for the signal peptide and the amphipathic domains in APOA4. These results suggest that the APOAI, APOC3, and APOA4 genes were derived from a common evolutionary ancestor and indicate that during evolution the APOA4 gene lost one of its ancestral introns. Two restriction endonuclease sites, an Xba I located in the second intron of the APOA4 gene and a different Xba I located 9 kilobases 3' to the APOA4 gene, are polymorphic in Mediterranean and Northern European populations. Haplotype analysis indicated that even though these polymorphic sites are located within 9 kilobases they do not display significant nonrandom association. Finally, restriction mapping analysis of DNA from a patient with combined APOAI-APOC3 deficiency and premature coronary artery disease indicated that this patient has a structurally normal APOA4 gene.
Apolipoproteins are lipid-binding proteins involved in the transport of triglycerides, phospholipids, and cholesterol in the plasma. Association of apolipoproteins with lipids results in formation of lipid-protein particles (lipoproteins), the major carriers of lipids in the intra-and extravascular space. Apolipoprotein A4 (APOA4) is synthesized primarily in the intestine (1, 2) and represents a major protein constituent of newly secreted intestinal triglyceride-rich lipoproteins (chylomicrons) (3) . The significant increase in APOA4 synthesis and secretion by the intestine during fat absorption (4) and the rapid dissociation of this protein from the surface of lymph chylomicrons during catabolism of these particles (5, 6) suggest that APOA4 plays a significant role in triglyceride metabolism. Similarly, the possible involvement of APOA4 in activation of lecithin-cholesterol acyltransferase [(LCAT) phosphatidylcholine-sterol acyltransferase; EC 2.3.1.43] (7) and the influence of the LCAT reaction on the distribution of APOA4 among different lipoproteins (8) may indicate that APOA4 is also involved in cholesterol metabolism.
The genes coding for apolipoproteins Al (APOAJ), C3 (APOC3), and A4 (APOA4) are closely linked and tandemly organized in the long arm of the human chromosome 11 (9) (10) (11) (12) . Several different DNA polymorphisms in this region of the human genome are associated with combined APOA1-APOC3 deficiency and premature coronary artery disease (13) (14) (15) , hypertriglyceridemia (16) , and hypoalphalipoproteinemia (17) .
In this report the nucleotide sequence of the human APOA4 gene has been determined. The results suggest that the APOAI, APOC3, and APOA4 genes were derived from a common evolutionary ancestor and indicate that during evolution the APOA4 gene lost one of its ancestral introns. Screening of the APOA4 gene region for polymorphisms showed that two different Xba I restriction endonuclease sites are polymorphic in Mediterranean and Northern European populations. Haplotype analysis indicated that these polymorphisms do not display significant nonrandom association. Finally, restriction mapping of the APOA4 gene region in a patient with combined APOA1-APOC3 deficiency and premature coronary artery disease indicated that this patient has a structurally normal APOA4 gene.
MATERIALS AND METHODS
Nucleotide Sequencing Determinations. DNA sequencing was carried out either by the base-specific chemical cleavage method (18) or by subcloning various DNA fragments in M13 vectors (19) and using the resulting single-stranded DNA templates for nucleotide sequence determination by the dideoxy chain-termination method (20) .
Isolation of DNA Fragments and Radioactive Labeling of Hybridization Probes. Cloned DNA fragments were isolated by electrophoresis in low-melting (Bio-Rad) agarose gels and purified by phenol extraction and ethanol precipitation. These fragments were labeled using [a-32P]dCTP (Amersham, 3000 Ci/mmol; 1 Ci = 37 GBq) as detailed (21) . S1 Nuclease Mapping and Primer-Extension. Purified restriction DNA fragments were treated with bacterial alkaline phosphatase according to the specifications of the vendor (IBI), extracted with phenol, precipitated with ethanol, and 5' end labeled with [y-32P]ATP (Amersham, 3000 Ci/mmol) using polynucleotide kinase (New England Biolabs). These 5' end-labeled fragments were used for S1 nuclease mapping (22) and primer-extension analysis (23) .
Genomic Restriction Mapping Analysis and Statistical Methods. Chromosomal DNA was prepared from peripheral blood of normal [with regard to coronary artery disease (17) ] individuals digested with restriction enzymes (New England Biolabs), electrophoresed in 1% agarose gels, transferred onto nitrocellulose filters (24) , and hybridized with 32P-labeled DNA probes. These filters were washed and used for autoradiography. Estimation of the nucleotide diversity (ir), heterozygosity (h), standardized nonrandom association (A), recombination frequency per kilobase (kb) ((D), and polymorphic information content (PIC value) was as described (25) (26) (27) (28) .
Abbreviations: PIC, polymorphic information content; APO-, apolipoprotein; kb, kilobase(s); bp, base pair(s); nt, nucleotide(s); LCAT, lecithin-cholesterol acyltransferase; IVS, intervening sequence; df, degree(s) of freedom.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (Fig. 2 ). This comparison also showed that polyadenylylation of the APOA4 mRNA occurs 22 residues 3' to the last nucleotide in the poly(A) signal (AATAAA) (Fig.   2 ). The start site (cap site) of this gene was determined by S1 nuclease mapping analysis of adult human intestine total RNA using as probe a 468-bp Msp I DNA fragment extending between nucleotides (nt) -334 and 134 (Fig. 2) . In addition, primer-extension analysis of this RNA was carried out by using as primer a 91-bp BamHI-Msp I DNA fragment extending between nt 45 and 134 (Fig. 2) . The resulting autoradiogram (Fig. 3) shows that S1 nuclease mapping (lane S) and primer-extension analysis (lane P) result in a 134-nt product. These data indicate that the start site of the human APOA4 gene is located 54 residues 3' to the last nucleotide of the TATA box (TTTAAAT) in this gene (Fig. 2) . DNA Polymorphisms and Nucleotide Diversity of the APOA4 Gene Region. Two DNA fragments containing APOA4 gene sequences, a 724-bp BamHI fragment extending between nt 39 and 763 (-probe I) and 1812-bp Sac I fragment extending between nt -3 and 1809 (probe II), were used as probes for restriction site polymorphism screening of Mediterranean and Northern European populations (Fig. 4) . Of the total 27 sites screened, only 2, an Xba I (XbaIA) located in the IVS2 of the APOA4 gene and a different Xba I (XbaIB) located 9 kb 3' to XbaIA, are polymorphic in both of these populations (Table 1 ). The sizes of hybridization fragments obtained with each of the nonpolymorphic sites (Table 1) are identical for every DNA sample studied (data not shown). Thus, the observed polymorphisms are most likely due to base substitutions rather than large deletions or insertions. Assuming that these base substitutions are selectively neutral it is possible to estimate the nucleotide diversity. (ir; refs. [25] [26] [27] over the 38-kb DNA segment containing the human APOA4 gene. The or values for the Mediterranean and Northern European populations are 0.0022 and 0.0020, respectively.
The combined data from both populations indicate a ir value of 0.0021. These results suggest that for this region of the human genome, on average, 1 in 483 bp is different between two randomly chosen chromosomes. The allele frequencies (p) and heterozygosities (h) of these DNA polymorphisms are very similar between the two populations studied ( Table 2 ). The average heterozygosities (hk) and overall average heterozygosities (h,) (26, 27) are also very similar among these two populations (Table 2) for the human growth hormone gene cluster and insulin gene locus (26, 27) . Estimation of the PIC values indicated that these polymorphisms are reasonably informative (28) for genetic linkage studies ( Table 2) . Association Between Polymorphic Sites in the APOA4 Gene Region. Random combination of the four possible haplotypes (+ + --, + -, and -+) of the XbaIA and XbaIB polymorphisms results in 10 possible genotypes (Fig. 4B) . Haplotyping of both chromosomes in any individual (without the need to study family members) can be accomplished by digestion of chromosomal DNA with Xba I and sequential hybridization with probes I and II (Fig. 4A) . The expected hybridization patterns for every possible genotype are shown in Fig. 4B . The hybridization patterns obtained for genotypes ++/++, ++/--, +-/--, and --/--are shown in Fig.   4C . The haplotype distribution among 34 Mediterranean and 66 Northern European chromosomes was determined. Of the four possible haplotypes, only three (+ +, + -, and --) were observed in both groups (Table 3) . For the Mediterraneans, the observed frequencies of haplotypes + +, + -, -+, and --are 0.294, 0.500, 0.000, and 0.205, respectively, whereas the corresponding expected frequencies, based on the observed frequency of each polymorphic site, are 0.233, 0.560, 0.059, and 0.143 (Table 3) . These results suggest that the XbaIA and XbaIB sites do not display significant linkage disequilibrium (x2 = 3.673, 1 df; A = 0.329). Similarly, for the Northern Europeans, the observed frequencies ofhaplotypes ++, +-, -+, and --are 0.212, 0.666, 0.000, and 0.121, respectively, whereas the corresponding expected frequencies are 0.186, 0.693, 0.025, and 0.095 (Table 3) . These results also suggest no significant linkage disequilibrium between the XbaIA and XbaIB sites (X2 = 2.451, 1 df; A = 0.193). The low linkage disequilibrium between these sites may indicate that these polymorphisms are ancient and that ample time has occurred for their random association. Alternatively, it is possible that the DNA segment between these sites is involved in recombination. In the latter case the standardized recombination frequency per kilobase (CF value) within this DNA segment can be estimated (27) patients with combined APOA1-APOC3 deficiency is associated with premature coronary artery disease (13) (14) (15) . The extent of this DNA rearrangement was determined by restriction mapping analysis of the APOA4 gene region in one of these patients. Specifically, chromosomal DNA, prepared from the blood of this patient, was mapped with BamHI, EcoRI, and Xba I using the APOA4 gene probe II (Fig. 4A) . The resulting autoradiogram (Fig. 5) shows that the sizes of the obtained hybridization fragments are identical to those expected for normal individuals (Fig. 4A) . These results indicate that the DNA rearrangement in the genome of this patient does not extend into the APOA4 gene region and that this patient has a structurally normal APOA4 gene. I  6  3  14  0  3  18  0  EcoRI  6  3  14  0  3  18  0  Bgl II   6  2  14  0  2  18  0  BamHI  6  3  14  0  3  18  0   Pst I  6  4  14  0  4  18  0  Msp I  4  4  24  0  4  44  0  Sac I  6  2  24  0  2  44  0  HindIII  6  2  24  0  2  44  0  Total  27  2  27 -2 r, Number of nucleotides at restriction site; s, number of restriction sites screened; n, number of chromosomes screened; k, number of polymorphic sites.
DISCUSSION
while the APOC3 gene was transposed between the APOA1 and APOA4 genes (29) . According to this phylogeny, the APOA4 gene arose by recent duplication of the APOAJ gene.
It therefore may be expected that these genes contain the same number of introns interrupting their coding regions at similar positions. However, in contrast to the APOAJ (30, 31) and APOC3 (32) genes, which contain three introns, the APOA4 gene contains only two. Alignment of the APOAJ, APOC3, and APOA4 mRNA sequences according to the initiation codons in the corresponding proteins indicates that introns separate nucleotide sequences coding for the signal peptides and the amphipathic domains in these proteins (Fig.  6) . It is tempting to speculate that the common evolutionary ancestor of these genes arose by shuffling (33) of exons coding for a signal peptide and for a peptide with amphipathic properties and that subsequent intraexonic recombinational amplification (12, 30) of this amphipathic peptide resulted in the present-day apolipoproteins. An intron (IVSJ) interrupting the 5' noncoding regions of the APOAI and APOC3 mRNAs is absent from the corresponding position in the APOA4 mRNA (Fig. 6) . It therefore appears that during evolution the APOA4 gene lost its ancestral IVSJ. Intron loss, during evolution, has been documented for several processed pseudogenes and for the semiprocessed rat and mouse preproinsulin I gene (34, 35) . It has been proposed that reinsertion (retroposition) into the genome of partially spliced, reverse-transcribed mRNA transcripts may give rise to new semiprocessed genes (36) . However, the close phys- (27) and suggests that, on the average, for two randomly selected chromosomes, 1 in 483 bp is variant. Thus, =79 such variants should exist. Haplotype analysis indicated that although these polymorphic sites are located within 9 kb they do not display significant nonrandom association. It is possible that these polymorphisms are ancient and that sufficient time has occurred for their random assortment. Alternatively, the DNA segment between these sites may be involved in recombination. Such recombinational hot spots have been found near the human insulin and /3-globin genes (27, 43) . Interestingly, the low levels of nonrandom association between these DNA polymorphisms increase their informativeness (PIC value) for genetic linkage studies (28, 45, 46) . Finally, it has been shown that a rearrangement of the APOAJ and APOC3 genes in the genome of two related patients with combined APOA1-APOC3 deficiency is associated with premature coronary artery disease (13) (14) (15) . Restriction mapping analysis of the APOA4 gene region in one of these patients indicated that this DNA rearrangement does not extend into the APOA4 gene. Although the presence of APOA4 in the plasma of these patients has not been determined, the relatively high levels of plasma LCAT activity (40% of normal; ref. 13 ) and the possible involvement of APOA4 in LCAT activation (7) suggest that the APOA4 gene of these patients is functionally normal. 
